1. Home
  2. AERT vs ALGS Comparison

AERT vs ALGS Comparison

Compare AERT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

N/A

Current Price

$7.10

Market Cap

39.7M

ML Signal

N/A

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$5.64

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
ALGS
Founded
2012
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
34.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AERT
ALGS
Price
$7.10
$5.64
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $39.33
AVG Volume (30 Days)
14.7K
★ 47.8K
Earning Date
02-09-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 110.87
88.30
EPS
★ 0.27
N/A
Revenue
★ $70,014,000.00
$2,186,000.00
Revenue This Year
N/A
$32.20
Revenue Next Year
N/A
$4.71
P/E Ratio
$26.81
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$3.98
52 Week High
$7.65
$13.69

Technical Indicators

Market Signals
Indicator
AERT
ALGS
Relative Strength Index (RSI) 52.10 48.64
Support Level $6.11 $4.81
Resistance Level $7.30 $5.94
Average True Range (ATR) 0.28 0.46
MACD -0.00 0.02
Stochastic Oscillator 64.19 54.62

Price Performance

Historical Comparison
AERT
ALGS

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: